MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$65,126K
Net Income
$3,630K
Net Profit Margin
5.57%
EPS
$0.65
Unit: Thousand (K) dollars
Revenue Breakdown
Sterilization And Disinfection C...
Biopharmaceutical Development
Calibration Solutions
Clinical Genomics
Revenue Breakdown
US
Other
CN
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Revenues
65,126
60,737
59,543
62,135
Cost of revenues
23,331
23,406
22,604
23,723
Gross profit
41,795
37,331
36,939
38,412
Selling
9,986
9,796
10,933
11,268
General and administrative
18,805
17,763
17,958
20,579
Research and development
5,029
5,048
4,984
5,096
Total operating expense
33,820
32,607
33,875
36,943
Operating income
7,975
4,724
3,064
1,469
Interest expense and amortization of debt issuance costs
3,036
2,862
2,198
3,157
Loss on extinguishment of convertible notes
0
0
0
-310
Other expense (income), net
-343
137
6,146
2,459
Total non-operating expense, net
-3,379
-2,725
3,948
-1,008
Earnings (loss) before income taxes
4,596
1,999
7,012
461
Income tax expense (benefit)
966
-477
2,270
7,575
Net income (loss)
3,630
2,476
4,742
-7,114
Basic EPS
0.66
0.45
0.87
-1.307
Diluted EPS
0.65
0.45
0.85
-1.327
Basic Average Shares
5,532,000
5,512,000
5,465,000
5,445,000
Diluted Average Shares
5,565,000
5,535,000
5,553,000
5,360,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Sterilization And
Disinfection Control
$24,914K
Biopharmaceutical Development
$14,373K
Calibration Solutions
$14,072K
Clinical Genomics
$11,767K
Revenues
$65,126K
(3.64%↑ Y/Y)
Gross profit
$41,795K
(5.13%↑ Y/Y)
Cost of revenues
$23,331K
(1.06%↑ Y/Y)
Operating income
$7,975K
(38.00%↑ Y/Y)
Total operating
expense
$33,820K
(-0.46%↓ Y/Y)
Earnings (loss) before
income taxes
$4,596K
(307.31%↑ Y/Y)
Total non-operating
expense, net
-$3,379K
(57.74%↑ Y/Y)
General and
administrative
$18,805K
(1.80%↑ Y/Y)
Selling
$9,986K
(-4.44%↓ Y/Y)
Research and development
$5,029K
(-0.47%↓ Y/Y)
Net income (loss)
$3,630K
(316.59%↑ Y/Y)
Income tax expense
(benefit)
$966K
(278.56%↑ Y/Y)
Interest expense and
amortization of debt issuance...
$3,036K
(6.83%↑ Y/Y)
Other expense
(income), net
-$343K
(93.34%↑ Y/Y)
Buy us a coffee
MESA LABORATORIES INC CO (MLAB)
MESA LABORATORIES INC CO (MLAB)